Pfizer Investigational Site — Wyomissing, Pennsylvania

Pfizer Investigational Site is a clinical research site located in Wyomissing, Pennsylvania, United States 19610.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Pfizer Investigational Site has participated in 13 clinical trials.

Therapeutic areas: Fibromyalgia, Ocular Hypertension, Glaucoma.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer, Ligand Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wyomissing

Browse all research sites in Pennsylvania · View every site in Wyomissing

• reading Hospital /ID# 223599
• Reading Hospital Study
• Reading Hospital/McGlinn Cancer Institute
• Clinical Research Center of Reading
• Research Site
• GSK Investigational Site
• Berks Cardiologists, LTD
• Radiant Research
• Respiratory Specialists
• Clinical Research Center of Reading LLP
• Digestive Disease Associates

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pfizer Investigational Site?

Pfizer Investigational Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pfizer Investigational Site conducted?

Pfizer Investigational Site has 13 clinical trials on record. Their work covers Fibromyalgia, Ocular Hypertension, Glaucoma.

Is Pfizer Investigational Site accredited by Crixeo Clinical Trials?

Pfizer Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pfizer Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.